The reported serious adverse events (SAEs) rates across the arms of Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) randomised controlled trials (RCTs) Saleh Almazam,Elaine Butterly,David McAllisterBRITISH JOURNAL OF PHARMACOLOGY（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
